Developer docs
API playgroundTry for free, no card

Search company profiles

BioLegend

Full company profile

uuid0007ps4

Namestring
BioLegend
Legal namestring
BioLegend, Inc.
Websiteurl
biolegend.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

BioLegend, headquartered in San Diego, California, is a life science reagent manufacturer specializing in antibody-based products, recombinant proteins, immunoassays, and cell separation tools for biomedical research and clinical applications. Its core catalog spans flow cytometry reagents (including Brilliant Violet™ and StarBright™ dyes), MojoSort™ magnetic cell separation kits, LEGENDplex™ multiplex immunoassays, ELISA kits, recombinant cytokines and growth factors, and the TotalSeq™ family of oligonucleotide-conjugated antibodies that bridge protein detection with single-cell RNA/DNA sequencing on 10x Genomics, Illumina, and Mission Bio platforms. The company also operates a GMP-compliant Cell-Vive™ ancillary materials portfolio for cell and gene therapy bioprocessing and a clinical IVD/ASR product line under ISO 13485:2016 quality systems.

The business operates a hybrid go-to-market combining direct e-commerce (biolegend.com and regional storefronts), field sales representatives for bulk and custom work, and an authorized distributor network covering more than 90 countries, with wholly-owned regional entities in the UK, Netherlands, Japan, China, and Germany. Revenue is generated primarily through one-time catalog sales of catalog antibodies, proteins, and kits, supplemented by professional services (custom conjugation, custom immunoassay development) and managed services (GMP contract manufacturing). Pricing is unit-based for standard SKUs and quote-based for custom and bulk orders. BioLegend has been a wholly-owned subsidiary of Revvity — the S&P 500 health science company spun off from PerkinElmer in 2023 with $2.7B+ in 2023 revenue — since the 2021 acquisition, and serves pharmaceutical/biotech firms, academic institutions, government research programs, clinical laboratories, and biopharmaceutical manufacturers across more than 190 end markets.

Short descriptiontext

BioLegend is a San Diego-based life science reagent company that develops and manufactures antibodies, recombinant proteins, immunoassays, and single-cell proteogenomics tools for academic, pharmaceutical, clinical diagnostics, and cell therapy manufacturing customers in 90+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antibody reagents, flow cytometry reagents, immunoassay kits, recombinant proteins, cell separation kits
Industry3 codes
1Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryYes
2Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
CodeHLAGAEABPrimaryNo
3Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods)
CodeHLAAABALPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Life Science Reagents
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Research Antibodies and Reagents
TypeOne Time License
Description

Sale of catalog antibodies and reagents for research applications including flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and other applications. Products are sold in various formats (purified, conjugated, lyophilized) with different fluorophore options.

biolegend.com
2Recombinant Proteins and Cytokines
TypeOne Time License
Description

Sale of bioactive recombinant proteins including cytokines, growth factors, chemokines, and enzymes for cell culture and research applications.

biolegend.com
3Immunoassays (ELISA and LEGENDplex™)
TypeOne Time License
Description

Multiplex and singleplex immunoassay kits for detecting analytes in biological samples. Includes pre-defined panels and custom configurations.

biolegend.com
4Custom Reagents and Conjugation Services
TypeProfessional Services
Description

Custom antibody conjugations, cocktail formulations (including fluorophore and TotalSeq™ options), custom recombinant proteins and antibodies, and custom ELISA/LEGENDplex configurations.

biolegend.com
5Custom Manufacturing Services
TypeManaged Services
Description

Contract manufacturing for research-grade and GMP-compliant materials including recombinant proteins, monoclonal/recombinant antibodies, cell culture media, and scalable production for bioprocessing applications.

biolegend.com
6Clinical Diagnostics (IVD and ASR)
TypeOne Time License
Description

In Vitro Diagnostic products and Analyte Specific Reagents for clinical laboratory use in immunophenotyping and diagnostic applications.

biolegend.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details3 tiers
1Standard catalog antibodies - purified and conjugated formats
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Product-specific pricing based on format and quantity. Example: Biotin anti-Tubulin β3 (TUBB3) - 25µg at $112, 100µg at $288. HRP anti-Tubulin β3 - 25µg at $136, 100µg at $335. APC anti-Tubulin β3 - 25 tests at $137, 100 tests at $350.

biolegend.com
2Shipping fees by product type and temperature requirements
ModelUnit PricingBilling cadencePer order
Notes

Ambient antibodies and ELISA kits: $45. Blue ice shipments: $50. Dry ice shipments: $60. LEGEND MAX™, LEGENDplex™, and LEGENDScreen™ kits: $50. Third party shipping handling fee: $25. Free shipping on orders over $1000 for US and Canada customers only.

biolegend.com
3Custom solutions and bulk orders
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing for custom conjugations, cocktails, and bulk orders. Discounts available for bulk quantities. Custom GMP services priced per project requirements.

biolegend.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BioLegend develops, manufactures, and distributes a catalog of thousands of antibody-based reagents for life science research, including flow cytometry antibodies, recombinant proteins (cytokines, growth factors, chemokines), multiplex immunoassays (LEGENDplex™), ELISA kits, and MojoSort™ magnetic cell separation products. The portfolio is anchored by proprietary platforms such as TotalSeq™ oligo-conjugated antibodies for single-cell proteogenomics, Flex-T™ MHC tetramers for antigen-specific T cell detection, and GMP-grade Cell-Vive™ ancillary materials for cell therapy bioprocessing, complemented by custom conjugation services and contract manufacturing for research and clinical applications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BioLegend is a life science reagent company offering a comprehensive portfolio of research tools organized around antibody-based products, immunoassays, and custom services. The core portfolio includes thousands of conjugated and unconjugated antibodies for flow cytometry, microscopy, Western blot, and immunohistochemistry applications, supplemented by recombinant proteins (cytokines, growth factors, chemokines), magnetic cell separation kits (MojoSort™), multiplex bead-based immunoassays (LEGENDplex™), and ELISA kits. TotalSeq™ oligo-conjugated antibodies enable proteogenomics workflows combining protein detection with single-cell RNA sequencing. The company provides GMP-grade Cell-Vive™ products for cell therapy bioprocessing and clinical IVD/ASR reagents for diagnostic laboratories. Custom solution capabilities include conjugation services, lyophilized antibody cocktails (XerosFlow™), custom immunoassay development, and contract manufacturing. Supporting web tools include spectral analyzers, panel builders, brightness indices, and a cloud-based Multiomics Analysis Software (MAS) for data analysis. BioLegend operates as part of Revvity and maintains ISO 13485:2016 compliant quality systems.

Product and service21 records
1Antibodies and Reagents
CategoryAntibodies
Description

Primary antibodies and reagents for flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and other immunological applications, offered in purified and conjugated formats with various fluorophore options.

2MojoSort™ Magnetic Cell Separation
CategoryCell Separation
Description

Magnetic cell separation system using negative selection to isolate untouched cells for downstream flow cytometry, cell culture, and molecular biology applications.

3Recombinant Proteins, Cytokines, Growth Factors
CategoryProteins
Description

Bioactive recombinant proteins including cytokines, growth factors, chemokines, and enzymes validated in functional bioassays for cell culture and research applications.

4Ultra-LEAF™ and GoInVivo™ Antibodies
CategoryAntibodies
Description

Low endotoxin, azide-free purified bulk antibodies for in vivo research, cell culture, functional assays, and bioprocessing applications.

5TotalSeq™ Oligo-Conjugated Antibodies
CategoryProteogenomics Reagents
Description

Oligonucleotide-conjugated antibodies available in TotalSeq-A, B, C, and D formats for simultaneous protein and RNA detection in single-cell RNA sequencing, high-parameter protein detection (PhenoCyte), and single-cell DNA analysis workflows.

6LEGENDplex™ Multiplex Immunoassays
CategoryImmunoassays
Description

Bead-based multiplex assays that use flow cytometry to simultaneously quantify multiple soluble analytes in biological samples, available in pre-defined panels and custom configurations.

7ELISA Kits
CategoryImmunoassays
Description

Enzyme-linked immunosorbent assay kits for detection and quantification of specific proteins in biological samples, including LEGEND MAX™ kits.

8FluoroSpot MAX™
CategoryImmunoassays
Description

Fluorescent spot assay for measuring multiple immune mediators such as IL-10, TNF-α, and IFN-γ in single wells to characterize complex immune responses.

9Flex-T™ MHC Tetramers and Monomers
CategoryImmunology Reagents
Description

Soluble MHC molecules assembled into tetramers using UV-labile peptide exchange technology for identifying antigen-specific T cells in vaccine development and cancer research.

10Cell-Vive™ GMP Portfolio
CategoryGMP Bioprocessing
Description

GMP-grade ancillary materials for cell therapy and ATMP bioprocessing, including antibodies and recombinant proteins compliant with USP<1043> and Ph. Eur. 5.2.12 for downstream manufacturing.

11StarBright™ Dyes
CategoryFluorophores
Description

Fluorescent dyes powered by Bio-Rad for conventional and spectral flow cytometry applications, licensed for RUO and clinical research use as antibody conjugates.

12Brilliant Violet™ Dyes
CategoryFluorophores
Description

Proprietary violet laser-excitable fluorescent dyes with minimized polymer dye interactions for multicolor flow cytometry panels.

13XerosFlow™ Lyophilized Cocktails
CategoryAntibody Cocktails
Description

Freeze-dried antibody cocktails with up to 24 months stability at room temperature (20-25°C), formulated with conventional fluorophores, Brilliant Violet™, and StarBright™ dyes to eliminate cold chain requirements.

14Clinical IVD and ASR Reagents
CategoryClinical Diagnostics
Description

In vitro diagnostic products and analyte-specific reagents for clinical laboratory use in immunophenotyping and diagnostic applications, including CE-marked products for the European market and ISO 13485:2016 compliant quality systems.

15Maxpar® Ready Antibodies
CategoryMass Cytometry Reagents
Description

Antibodies that can be metal-labeled for use in CyTOF® mass cytometry applications.

16Custom Conjugation and Cocktail Services
CategoryCustom Services
Description

Custom fluorophore and oligo conjugations, plus antibody cocktails in liquid, XerosFlow™ dry, and lyophilized formats, including Brilliant Violet™ and TotalSeq™ options tailored to specific experimental needs.

17Custom ELISA and LEGENDplex™ Immunoassays
CategoryCustom Services
Description

Custom multiplex immunoassays for quantifying multiple analytes in biological samples, with the ability to combine analytes across multiple kits.

18Contract Manufacturing Services
CategoryCustom Services
Description

GMP-compliant custom manufacturing for research-grade and bioprocessing-grade materials, including recombinant proteins, monoclonal and recombinant antibodies, cell culture media, and scalable production for cell therapy and bioprocessing applications.

19Flow Cytometry Panel Construction Service
CategoryCustom Services
Description

Expert panel design and optimization services provided by immunologists and flow cytometry specialists for building optimized multicolor flow cytometry panels.

20Multiomics Analysis Software (MAS)
CategorySoftware
Description

Free cloud-based software for analyzing single-cell RNA and protein data from TotalSeq™ multiomics experiments, designed for users without bioinformatics expertise.

21Fontus™ Cytometry Cocktail Prep Workstation
CategoryInstruments
Description

Automated workstation for optimized antibody cocktail preparation and staining, enhancing precision, standardization, productivity, and traceability in clinical flow cytometry, linked with Revvity's clinical IVD product line.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1The Michael J. Fox Foundation for Parkinson's Research
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

BioLegend is a participant and sponsor of the MJFF-led Parkinson's Progression Markers Initiative (PPMI), contributing data and samples for NIH AMP program. BioLegend's LEGEND MAX Human α-Synuclein ELISA kit has been used extensively in PPMI multi-centered studies. The partnership was built in collaboration with preeminent neuroscience leaders.

biolegend.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

NIH and the Michael J. Fox Foundation partnership program for Parkinson's Disease research as part of the NIH Accelerating Medicines Partnership (AMP). BioLegend contributes as participant and sponsor for the PPMI initiative.

Strategic tierCoreTypeOthers
Description

BioLegend is now part of Revvity, a health science solutions company (spun off from PerkinElmer in 2023) with 2023 revenue of more than $2.7 billion and over 11,000 employees. Revvity provides complete workflows from discovery to development, and diagnosis to cure, with focus areas in translational multi-omics technologies, biomarker identification, imaging, and diagnostics.

Strategic tierCoreTypeTechnology or Integration
Description

Collaboration on BEN-seq workflow developed by BioLegend, where cells in suspension are stained with TotalSeq antibodies prior to bulk RNA sequencing using Illumina platforms. Enables combined protein and RNA analysis in bulk sequencing applications.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership for single-cell DNA and protein detection using TotalSeq-D reagents with Mission Bio's Tapestri platform. Enables resolution of complex genetic questions by combining single-cell DNA analysis with protein detection.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership for StarBright™ dyes (powered by Bio-Rad), fluorescent dyes for flow cytometry applications. StarBright conjugates are available for RUO and clinical research applications according to end user design specifications.

Strategic tierCoreTypeTechnology or Integration
Description

Cross-selling and integrated product offerings within Revvity family. BioLegend IVD products link to Revvity's Fontus™ Cytometry Cocktail Prep Workstation for automated liquid handling. BioLegend TotalSeq reagents cross-promoted with Revvity single-cell sequencing products.

Strategic tierCoreTypeTechnology or Integration
Description

TotalSeq reagents are compatible with 10x Genomics single-cell platforms for simultaneous protein and RNA detection in single-cell RNA sequencing workflows.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Extensive network of authorized distributors covering over 90 countries. Major regional distributors include Cedarlane (Canada), Nordic Biosite (Nordic countries), Biomedica group (Central/Eastern Europe), and many specialized distributors in Asia-Pacific, Latin America, Middle East, and Africa.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bio-Rad is BioLegend's most direct competitor in flow cytometry reagents and is also a technology partner (StarBright™ dyes are powered by Bio-Rad). Both companies sell antibody panels, dyes, and instrumentation consumables to immunology, cancer, and cell biology researchers globally.

TypeBroad incumbent
Description

Thermo Fisher's life sciences brands (Invitrogen, eBioscience, Gibco, Thermo Scientific) offer an overlapping portfolio of research antibodies, recombinant proteins, cell culture reagents, and flow cytometry consumables. As a large incumbent, it competes with BioLegend across most catalog reagent categories and benefits from a much broader instrument and services footprint.

TypeDirect peer
Description

BD Biosciences is a leading provider of flow cytometry instruments and reagent kits, including fluorescent antibodies, multiplex bead arrays, and clinical IVD flow cytometry products. It directly competes with BioLegend in clinical and research flow cytometry and is a global incumbent in the installed-instrument base.

TypeDirect peer
Description

Miltenyi Biotec is a global competitor in magnetic cell separation (MACS®), flow cytometry reagents, and cell therapy manufacturing reagents — directly competing with BioLegend's MojoSort™ and cell-therapy-adjacent reagent portfolio. It has built an end-to-end cell therapy manufacturing offering that parallels Cell-Vive™.

TypeDirect peer
Description

CST is a leading provider of highly validated antibodies and reagents, with a strong reputation in cell signaling, cancer, and neuroscience research — directly comparable to BioLegend's content library and validation-led positioning. CST competes on antibody specificity, reproducibility, and application support across Western blot, IHC, and flow cytometry.

TypeDirect peer
Description

Bio-Techne is a major competitor in recombinant proteins, cytokines/growth factors, ELISA kits, and research antibodies (via R&D Systems, Novus, and Tocris). It overlaps directly with BioLegend's recombinant protein and immunoassay businesses, including in GMP and cell therapy reagent adjacencies.

TypeDirect peer
Description

Abcam is one of the largest research antibody catalog businesses globally, offering polyclonal, monoclonal, and recombinant antibodies across essentially the same research applications as BioLegend (flow cytometry, IHC, Western blot, IF). It is a direct horizontal competitor in catalog antibody breadth and pricing.

TypeDirect peer
Description

Cytek is a leading provider of spectral flow cytometry instruments and reagents; it directly competes with BioLegend in advanced flow cytometry workflows and benefits from instrument–reagent cross-selling similar in concept to BioLegend's Brilliant Violet™ and StarBright™ reagent strategies.

TypeEmerging player
Description

10x Genomics is BioLegend's single-cell sequencing platform partner (TotalSeq™ is compatible with 10x workflows) and an emerging adjacent player in single-cell multiomics reagents. It is a peer in the broader single-cell ecosystem where strategic choices by 10x can materially affect TotalSeq™'s positioning.

TypeEmerging player
Description

Standard BioTools markets the CyTOF®/Hyperion® mass cytometry platform and Maxpar® metal-tagged antibody panel reagents — BioLegend sells Maxpar® Ready antibodies into the same workflow, making Standard BioTools a partially overlapping player in high-parameter cellular profiling.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioLegend

Life Science Reagentsbiolegend.com

BioLegend is a San Diego-based life science reagent company that develops and manufactures antibodies, recombinant proteins, immunoassays, and single-cell proteogenomics tools for academic, pharmaceutical, clinical diagnostics, and cell therapy manufacturing customers in 90+ countries.

What BioLegend does

BioLegend, headquartered in San Diego, California, is a life science reagent manufacturer specializing in antibody-based products, recombinant proteins, immunoassays, and cell separation tools for biomedical research and clinical applications. Its core catalog spans flow cytometry reagents (including Brilliant Violet™ and StarBright™ dyes), MojoSort™ magnetic cell separation kits, LEGENDplex™ multiplex immunoassays, ELISA kits, recombinant cytokines and growth factors, and the TotalSeq™ family of oligonucleotide-conjugated antibodies that bridge protein detection with single-cell RNA/DNA sequencing on 10x Genomics, Illumina, and Mission Bio platforms. The company also operates a GMP-compliant Cell-Vive™ ancillary materials portfolio for cell and gene therapy bioprocessing and a clinical IVD/ASR product line under ISO 13485:2016 quality systems.

The business operates a hybrid go-to-market combining direct e-commerce (biolegend.com and regional storefronts), field sales representatives for bulk and custom work, and an authorized distributor network covering more than 90 countries, with wholly-owned regional entities in the UK, Netherlands, Japan, China, and Germany. Revenue is generated primarily through one-time catalog sales of catalog antibodies, proteins, and kits, supplemented by professional services (custom conjugation, custom immunoassay development) and managed services (GMP contract manufacturing). Pricing is unit-based for standard SKUs and quote-based for custom and bulk orders. BioLegend has been a wholly-owned subsidiary of Revvity — the S&P 500 health science company spun off from PerkinElmer in 2023 with $2.7B+ in 2023 revenue — since the 2021 acquisition, and serves pharmaceutical/biotech firms, academic institutions, government research programs, clinical laboratories, and biopharmaceutical manufacturers across more than 190 end markets.

BioLegend firmographics

Firmographics
Name
BioLegend
Legal name
BioLegend, Inc.
Website
https://biolegend.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
501–1,000 employees
Short description
BioLegend is a San Diego-based life science reagent company that develops and manufactures antibodies, recombinant proteins, immunoassays, and single-cell proteogenomics tools for academic, pharmaceutical, clinical diagnostics, and cell therapy manufacturing customers in 90+ countries.
Ownership category
akta.pro rank

BioLegend industry classification

Industry
Product category
Life Science Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
akta.pro secondary industries
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods) (HLAAABAL)

Keywords

  • Antibody reagents
  • Flow cytometry reagents
  • Immunoassay kits
  • Recombinant proteins
  • Cell separation kits

Where BioLegend is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices6 records

Markets served

BioLegend business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Research Antibodies and Reagents: Sale of catalog antibodies and reagents for research applications including flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and other applications. Products are sold in various formats (purified, conjugated, lyophilized) with different fluorophore options.
  2. Recombinant Proteins and Cytokines: Sale of bioactive recombinant proteins including cytokines, growth factors, chemokines, and enzymes for cell culture and research applications.
  3. Immunoassays (ELISA and LEGENDplex™): Multiplex and singleplex immunoassay kits for detecting analytes in biological samples. Includes pre-defined panels and custom configurations.
  4. Custom Reagents and Conjugation Services: Custom antibody conjugations, cocktail formulations (including fluorophore and TotalSeq™ options), custom recombinant proteins and antibodies, and custom ELISA/LEGENDplex configurations.
  5. Custom Manufacturing Services: Contract manufacturing for research-grade and GMP-compliant materials including recombinant proteins, monoclonal/recombinant antibodies, cell culture media, and scalable production for bioprocessing applications.
  6. Clinical Diagnostics (IVD and ASR): In Vitro Diagnostic products and Analyte Specific Reagents for clinical laboratory use in immunophenotyping and diagnostic applications.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard catalog antibodies - purified and conjugated formats
Unit PricingPer orderShipping fees by product type and temperature requirements
OtherMulti-year contractCustom solutions and bulk orders

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

BioLegend product offering

Product offering

Core offering

BioLegend develops, manufactures, and distributes a catalog of thousands of antibody-based reagents for life science research, including flow cytometry antibodies, recombinant proteins (cytokines, growth factors, chemokines), multiplex immunoassays (LEGENDplex™), ELISA kits, and MojoSort™ magnetic cell separation products. The portfolio is anchored by proprietary platforms such as TotalSeq™ oligo-conjugated antibodies for single-cell proteogenomics, Flex-T™ MHC tetramers for antigen-specific T cell detection, and GMP-grade Cell-Vive™ ancillary materials for cell therapy bioprocessing, complemented by custom conjugation services and contract manufacturing for research and clinical applications.

Product overview

BioLegend is a life science reagent company offering a comprehensive portfolio of research tools organized around antibody-based products, immunoassays, and custom services. The core portfolio includes thousands of conjugated and unconjugated antibodies for flow cytometry, microscopy, Western blot, and immunohistochemistry applications, supplemented by recombinant proteins (cytokines, growth factors, chemokines), magnetic cell separation kits (MojoSort™), multiplex bead-based immunoassays (LEGENDplex™), and ELISA kits. TotalSeq™ oligo-conjugated antibodies enable proteogenomics workflows combining protein detection with single-cell RNA sequencing. The company provides GMP-grade Cell-Vive™ products for cell therapy bioprocessing and clinical IVD/ASR reagents for diagnostic laboratories. Custom solution capabilities include conjugation services, lyophilized antibody cocktails (XerosFlow™), custom immunoassay development, and contract manufacturing. Supporting web tools include spectral analyzers, panel builders, brightness indices, and a cloud-based Multiomics Analysis Software (MAS) for data analysis. BioLegend operates as part of Revvity and maintains ISO 13485:2016 compliant quality systems.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antibodies and Reagents Primary antibodies and reagents for flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and other immunological applications, offered in purified and conjugated formats with various fluorophore options.
  • MojoSort™ Magnetic Cell Separation Magnetic cell separation system using negative selection to isolate untouched cells for downstream flow cytometry, cell culture, and molecular biology applications.
  • Recombinant Proteins, Cytokines, Growth Factors Bioactive recombinant proteins including cytokines, growth factors, chemokines, and enzymes validated in functional bioassays for cell culture and research applications.
  • Ultra-LEAF™ and GoInVivo™ Antibodies Low endotoxin, azide-free purified bulk antibodies for in vivo research, cell culture, functional assays, and bioprocessing applications.
  • TotalSeq™ Oligo-Conjugated Antibodies Oligonucleotide-conjugated antibodies available in TotalSeq-A, B, C, and D formats for simultaneous protein and RNA detection in single-cell RNA sequencing, high-parameter protein detection (PhenoCyte), and single-cell DNA analysis workflows.
  • LEGENDplex™ Multiplex Immunoassays Bead-based multiplex assays that use flow cytometry to simultaneously quantify multiple soluble analytes in biological samples, available in pre-defined panels and custom configurations.
  • ELISA Kits Enzyme-linked immunosorbent assay kits for detection and quantification of specific proteins in biological samples, including LEGEND MAX™ kits.
  • FluoroSpot MAX™ Fluorescent spot assay for measuring multiple immune mediators such as IL-10, TNF-α, and IFN-γ in single wells to characterize complex immune responses.
  • Flex-T™ MHC Tetramers and Monomers Soluble MHC molecules assembled into tetramers using UV-labile peptide exchange technology for identifying antigen-specific T cells in vaccine development and cancer research.
  • Cell-Vive™ GMP Portfolio GMP-grade ancillary materials for cell therapy and ATMP bioprocessing, including antibodies and recombinant proteins compliant with USP<1043> and Ph. Eur. 5.2.12 for downstream manufacturing.
  • StarBright™ Dyes Fluorescent dyes powered by Bio-Rad for conventional and spectral flow cytometry applications, licensed for RUO and clinical research use as antibody conjugates.
  • Brilliant Violet™ Dyes Proprietary violet laser-excitable fluorescent dyes with minimized polymer dye interactions for multicolor flow cytometry panels.
  • XerosFlow™ Lyophilized Cocktails Freeze-dried antibody cocktails with up to 24 months stability at room temperature (20-25°C), formulated with conventional fluorophores, Brilliant Violet™, and StarBright™ dyes to eliminate cold chain requirements.
  • Clinical IVD and ASR Reagents In vitro diagnostic products and analyte-specific reagents for clinical laboratory use in immunophenotyping and diagnostic applications, including CE-marked products for the European market and ISO 13485:2016 compliant quality systems.
  • Maxpar® Ready Antibodies Antibodies that can be metal-labeled for use in CyTOF® mass cytometry applications.
  • Custom Conjugation and Cocktail Services Custom fluorophore and oligo conjugations, plus antibody cocktails in liquid, XerosFlow™ dry, and lyophilized formats, including Brilliant Violet™ and TotalSeq™ options tailored to specific experimental needs.
  • Custom ELISA and LEGENDplex™ Immunoassays Custom multiplex immunoassays for quantifying multiple analytes in biological samples, with the ability to combine analytes across multiple kits.
  • Contract Manufacturing Services GMP-compliant custom manufacturing for research-grade and bioprocessing-grade materials, including recombinant proteins, monoclonal and recombinant antibodies, cell culture media, and scalable production for cell therapy and bioprocessing applications.
  • Flow Cytometry Panel Construction Service Expert panel design and optimization services provided by immunologists and flow cytometry specialists for building optimized multicolor flow cytometry panels.
  • Multiomics Analysis Software (MAS) Free cloud-based software for analyzing single-cell RNA and protein data from TotalSeq™ multiomics experiments, designed for users without bioinformatics expertise.
  • Fontus™ Cytometry Cocktail Prep Workstation Automated workstation for optimized antibody cocktail preparation and staining, enhancing precision, standardization, productivity, and traceability in clinical flow cytometry, linked with Revvity's clinical IVD product line.

Companies that use BioLegend

Customer profile

Named customers4 records

Segments7 records

Ideal customer profiles4 records

BioLegend technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

BioLegend partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship and core.

  • The Michael J. Fox Foundation for Parkinson's ResearchflagshipStrategic or Co-development Partner · 1 January 2026BioLegend is a participant and sponsor of the MJFF-led Parkinson's Progression Markers Initiative (PPMI), contributing data and samples for NIH AMP program. BioLegend's LEGEND MAX Human α-Synuclein ELISA kit has been used extensively in PPMI multi-centered studies. The partnership was built in collaboration with preeminent neuroscience leaders.
  • NIH (National Institutes of Health)flagshipStrategic or Co-development Partner · 1 January 2026NIH and the Michael J. Fox Foundation partnership program for Parkinson's Disease research as part of the NIH Accelerating Medicines Partnership (AMP). BioLegend contributes as participant and sponsor for the PPMI initiative.
  • RevvitycoreOthersBioLegend is now part of Revvity, a health science solutions company (spun off from PerkinElmer in 2023) with 2023 revenue of more than $2.7 billion and over 11,000 employees. Revvity provides complete workflows from discovery to development, and diagnosis to cure, with focus areas in translational multi-omics technologies, biomarker identification, imaging, and diagnostics.
  • IlluminacoreTechnology or IntegrationCollaboration on BEN-seq workflow developed by BioLegend, where cells in suspension are stained with TotalSeq antibodies prior to bulk RNA sequencing using Illumina platforms. Enables combined protein and RNA analysis in bulk sequencing applications.
  • Mission BiocoreTechnology or IntegrationPartnership for single-cell DNA and protein detection using TotalSeq-D reagents with Mission Bio's Tapestri platform. Enables resolution of complex genetic questions by combining single-cell DNA analysis with protein detection.
  • Bio-Rad LaboratoriescoreTechnology or IntegrationPartnership for StarBright™ dyes (powered by Bio-Rad), fluorescent dyes for flow cytometry applications. StarBright conjugates are available for RUO and clinical research applications according to end user design specifications.
  • Revvity (Intra-company)coreTechnology or IntegrationCross-selling and integrated product offerings within Revvity family. BioLegend IVD products link to Revvity's Fontus™ Cytometry Cocktail Prep Workstation for automated liquid handling. BioLegend TotalSeq reagents cross-promoted with Revvity single-cell sequencing products.
  • 10x GenomicscoreTechnology or IntegrationTotalSeq reagents are compatible with 10x Genomics single-cell platforms for simultaneous protein and RNA detection in single-cell RNA sequencing workflows.
  • Worldwide DistributorscoreChannel Partner/ Reseller/ DistributorExtensive network of authorized distributors covering over 90 countries. Major regional distributors include Cedarlane (Canada), Nordic Biosite (Nordic countries), Biomedica group (Central/Eastern Europe), and many specialized distributors in Asia-Pacific, Latin America, Middle East, and Africa.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

BioLegend competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Bio-Rad is BioLegend's most direct competitor in flow cytometry reagents and is also a technology partner (StarBright™ dyes are powered by Bio-Rad). Both companies sell antibody panels, dyes, and instrumentation consumables to immunology, cancer, and cell biology researchers globally.
  • BD Biosciences: BD Biosciences is a leading provider of flow cytometry instruments and reagent kits, including fluorescent antibodies, multiplex bead arrays, and clinical IVD flow cytometry products. It directly competes with BioLegend in clinical and research flow cytometry and is a global incumbent in the installed-instrument base.
  • Miltenyi Biotec: Miltenyi Biotec is a global competitor in magnetic cell separation (MACS®), flow cytometry reagents, and cell therapy manufacturing reagents — directly competing with BioLegend's MojoSort™ and cell-therapy-adjacent reagent portfolio. It has built an end-to-end cell therapy manufacturing offering that parallels Cell-Vive™.
  • Cell Signaling Technology (CST): CST is a leading provider of highly validated antibodies and reagents, with a strong reputation in cell signaling, cancer, and neuroscience research — directly comparable to BioLegend's content library and validation-led positioning. CST competes on antibody specificity, reproducibility, and application support across Western blot, IHC, and flow cytometry.
  • Bio-Techne (R&D Systems / Novus Biologicals / Tocris): Bio-Techne is a major competitor in recombinant proteins, cytokines/growth factors, ELISA kits, and research antibodies (via R&D Systems, Novus, and Tocris). It overlaps directly with BioLegend's recombinant protein and immunoassay businesses, including in GMP and cell therapy reagent adjacencies.
  • Abcam: Abcam is one of the largest research antibody catalog businesses globally, offering polyclonal, monoclonal, and recombinant antibodies across essentially the same research applications as BioLegend (flow cytometry, IHC, Western blot, IF). It is a direct horizontal competitor in catalog antibody breadth and pricing.
  • Cytek Biosciences: Cytek is a leading provider of spectral flow cytometry instruments and reagents; it directly competes with BioLegend in advanced flow cytometry workflows and benefits from instrument–reagent cross-selling similar in concept to BioLegend's Brilliant Violet™ and StarBright™ reagent strategies.

Broad incumbents

  • Thermo Fisher Scientific (Invitrogen / eBioscience / Gibco): Thermo Fisher's life sciences brands (Invitrogen, eBioscience, Gibco, Thermo Scientific) offer an overlapping portfolio of research antibodies, recombinant proteins, cell culture reagents, and flow cytometry consumables. As a large incumbent, it competes with BioLegend across most catalog reagent categories and benefits from a much broader instrument and services footprint.

Emerging players

  • 10x Genomics: 10x Genomics is BioLegend's single-cell sequencing platform partner (TotalSeq™ is compatible with 10x workflows) and an emerging adjacent player in single-cell multiomics reagents. It is a peer in the broader single-cell ecosystem where strategic choices by 10x can materially affect TotalSeq™'s positioning.
  • Standard BioTools (formerly Fluidigm): Standard BioTools markets the CyTOF®/Hyperion® mass cytometry platform and Maxpar® metal-tagged antibody panel reagents — BioLegend sells Maxpar® Ready antibodies into the same workflow, making Standard BioTools a partially overlapping player in high-parameter cellular profiling.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

BioLegend social profiles

Digital presence

BioLegend compliance and trust

Trust signal

Compliance2 records

BioLegend financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioLegend leadership team

Management profile

Number of profiles

Profiles3 records

BioLegend subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

BioLegend funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioLegend M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioLegend

What does BioLegend do?

BioLegend develops, manufactures, and distributes a catalog of thousands of antibody-based reagents for life science research, including flow cytometry antibodies, recombinant proteins (cytokines, growth factors, chemokines), multiplex immunoassays (LEGENDplex™), ELISA kits, and MojoSort™ magnetic cell separation products. The portfolio is anchored by proprietary platforms such as TotalSeq™ oligo-conjugated antibodies for single-cell proteogenomics, Flex-T™ MHC tetramers for antigen-specific T cell detection, and GMP-grade Cell-Vive™ ancillary materials for cell therapy bioprocessing, complemented by custom conjugation services and contract manufacturing for research and clinical applications.

Is BioLegend a public or private company?

BioLegend is a private company. It is classified as corporate owned and is currently operating.

When was BioLegend founded?

BioLegend was founded in 2002. It employs 501 to 1,000 people.

Where is BioLegend based?

BioLegend is headquartered in San Diego, United States, in the North America region.

How does BioLegend make money?

Six revenue lines are on record. Research Antibodies and Reagents are the primary driver. The others are recombinant Proteins and Cytokines, immunoassays (ELISA and LEGENDplex™), custom Reagents and Conjugation Services, custom Manufacturing Services and clinical Diagnostics (IVD and ASR).

Who are BioLegend's main competitors?

Direct peers on record are Bio-Rad Laboratories, BD Biosciences, Miltenyi Biotec, Cell Signaling Technology (CST), Bio-Techne (R&D Systems / Novus Biologicals / Tocris), Abcam and Cytek Biosciences. Thermo Fisher Scientific (Invitrogen / eBioscience / Gibco) is listed as a broad incumbent. Emerging players are 10x Genomics and Standard BioTools (formerly Fluidigm).

Does BioLegend have an API?

No public API is recorded for BioLegend.

What industry is BioLegend in?

BioLegend's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
OpexAdvancements in Cold Chain Logistics for PharmaceuticalsOPEX is promoting its warehouse automation solutions, such as the Perfect Pick® HD and Infinity® AS/RS systems, to address the complex temperature control and efficiency requirements of pharmaceutical cold chain logistics. The article highlights a specific implementation at BioLegend, where these systems manage high-value products in cold storage while keeping employees out of harsh conditions. This approach aims to maintain product integrity, ensure regulatory compliance, and optimize energy usage through automated handling.AscpM&A Report: The Top 10 Diagnostics Deals of 2021A report ranks the top 10 medical diagnostics M&A deals of 2021 by value, noting seven billion-dollar acquisitions, up from six in 2020. Thermo Fisher's $17.4 billion cash purchase of PPD led the list, followed by Siemens' $16.4 billion cash buy of Varian. PerkinElmer made four deals, including BioLegend and Oxford Immunotec.AxiosPerkinElmer acquires antibodies developer BioLegend for $5.25 billionPerkinElmer agreed to acquire antibodies developer BioLegend for $5.25 billion in cash and stock. The deal aims to expand PerkinElmer's laboratory equipment business into selling antibodies for research, including COVID-19 studies.MedTech DivePerkinElmer inks $5.3B takeover of antibody provider BioLegendPerkinElmer has agreed to acquire antibody provider BioLegend for $5.25 billion to expand its discovery and analytical solutions business. This deal follows a series of acquisitions this year, including Immunodiagnostic Systems Holdings, Nexcelom Bioscience, and Oxford Immunotec, bringing their combined value to approximately $1 billion. The acquisition coincides with PerkinElmer's second-quarter results that beat expectations, leading the company to raise its full-year guidance by $200 million to $4.57 billion.BenzingaPerkinElmer To Acquire Lifescience Firm BioLegend For $5B; Q2 Earnings Beat EstimatesPerkinElmer Inc has agreed to acquire privately-held BioLegend for $5.25 billion in cash and stock, with the deal expected to close by the end of 2021. The acquisition will expand PerkinElmer's life science franchise, with expected EPS accretion of $0.30 in the first full year and greater than $0.50 in the second year, plus revenue synergies estimated to reach $100 million annually by the fifth year. PerkinElmer also reported Q2 adjusted EPS of $2.83, beating the consensus of $2.41, with sales of $1.23 billion up 51% year-over-year, and raised its full-year 2021 adjusted EPS outlook to $9.88.